Overview

Effectiveness of Pramipexole for Treatment-Resistant Depression

Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the effectiveness of pramipexole (Mirapex) in managing treatment-resistant depression.
Phase:
Phase 4
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Pramipexole